Vanda Pharmaceuticals (VNDA) Profit After Tax (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Profit After Tax of -$48.6 million for Q1 2026, down 64.67% on a YoY basis from -$137.5 million in Q1 2025, and up 65.6% sequentially from -$141.2 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) Profit After Tax (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Profit After Tax data on file, last reported at -$48.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 64.67% year-over-year to -$48.6 million; the trailing twelve-month figure through Mar 2026 stood at -$239.5 million (down 441.37% YoY), and the FY2025 full-year result was -$220.5 million, down 1066.53% from the prior year.
- Profit After Tax improved to -$48.6 million in Q1 2026, from -$141.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $6.9 million in Q4 2022 to a low of -$141.2 million in Q4 2025.
- A 5-year average of -$16.4 million and a median of -$4.5 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 150.58% in 2023 and tumbled 3986.13% in 2024, its largest moves.
- Tracing VNDA's Profit After Tax over 5 years: stood at $6.9 million in 2022, then slumped by 134.98% to -$2.4 million in 2023, then plunged by 104.67% to -$4.9 million in 2024, then sank by 2774.33% to -$141.2 million in 2025, then soared by 65.6% to -$48.6 million in 2026.
- Business Quant data shows VNDA's Profit After Tax at -$48.6 million in Q1 2026, -$141.2 million in Q4 2025, and -$22.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Vanda Pharmaceuticals | 309.49 Mn | 107.18 Mn | 48.56 Mn | -48.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.57 Mn |
| Dec 31, 2025 | -141.19 Mn |
| Sep 30, 2025 | -22.59 Mn |
| Jun 30, 2025 | -27.21 Mn |
| Mar 31, 2025 | -29.49 Mn |
| Dec 31, 2024 | -4.91 Mn |
| Sep 30, 2024 | -5.32 Mn |
| Jun 30, 2024 | -4.52 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -2.40 Mn |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 3.25 Mn |
| Dec 31, 2022 | 6.86 Mn |
| Sep 30, 2022 | 3.27 Mn |
| Jun 30, 2022 | 2.57 Mn |
| Mar 31, 2022 | -6.43 Mn |
| Dec 31, 2021 | 7.08 Mn |
| Sep 30, 2021 | 7.77 Mn |
| Jun 30, 2021 | 9.65 Mn |